The occurrence of non‐anatomical therapeutic chemical‐international nonproprietary name molecules in suspected illegal or illegally traded health products in Europe: A retrospective and prospective study

Author:

Deconinck Eric12ORCID,Vanhee Celine2ORCID,Keizers Peter13ORCID,Guinot Pauline14,Mihailova Albena5,Syversen Per Vidar15,Li‐Ship Graziella16,Young Steven6,Blazewicz Agata17ORCID,Poplawska Magdalena7,Al‐Sayed Josephine Loasby8,Stengelshøj Olsen Lone18,el‐Atma Oliver9,Leist Roman110,Jönsson Karl‐Henrik111,Afxentiou Maria112,Barrios M. Mendoza113,Diaz I. Dorronsoro13,Zemser Marina114,Kozokin Alla14,Hackl Andreas115,Portela Maria‐Jao116,Beerbaum Nico17,Bertrand Marie1

Affiliation:

1. OMCL Falsified Medicines Working Group, GEON Network EDQM—Council of Europe Strasbourg France

2. Scientific Direction Chemical and Physical Health Risks, Service of Medicines and Health Products Sciensano Brussels Belgium

3. Department of Product Composition National Institute for Public Health and the Environment Bilthoven The Netherlands

4. Laboratory Controls Division French National Agency for Medicines and Health Products Safety Vendargues France

5. Laboratory, Division Reliable Supply Norwegian Medicines Agency Oslo Norway

6. Inspections, Enforcement and Standards Division Medicines and Healthcare Products Regulatory Agency London UK

7. Falsified Medicines and medical Devices Department National Medicines Institute Warsaw Poland

8. Medicines Control and Inspection Division Danish Medicines Agency Copenhagen Denmark

9. Medicinal Products Chemical and Veterinary Investigation Office Karlsruhe Germany

10. OMCL Swissmedic, Swiss Agency for Therapeutic Products Bern Switzerland

11. Laboratory Department Swedish Medical Products Agency Uppsala Sweden

12. Forensic Chemistry and Toxicology Laboratory State General Laboratory Nicosia Cyprus

13. Chemical and Pharmaceutical Division, Medicines for Human Use Department Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) Madrid Spain

14. Institute of Standardization and Control of Pharmaceuticals Ministry of Health Israel Jerusalem Israel

15. Institute Assessment & Analytics, Analytics of chemical‐pharmaceutical Medicinal Products AGES—Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH Wien Austria

16. Direção de Comprovação da Qualidade INFARMED—Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. Lisbon Portugal

17. Institut für Lebensmittel, Arzneimittel, Tierseuchen und Umwelt Landeslabor Berlin‐Brandenburg Berlin Germany

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Reference26 articles.

1. https://www.edqm.eu/en/general-european-omcl-network-geon(last accessed 28/10/2020).

2. European directive 2004/28/CEE;European Parliament;Off J Eur Union,2004

3. https://www.edqm.eu/en/edqms-response-nitrosamine-contamination(last accessed 28/10/2020).

4. World Health Organization Substandard and falsified medical products (2018).http://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products(last accessed 28/10/2020).

5. International Medical Products Anti‐Counterfeiting Taskforce (IMPACT).Counterfeit drugs kill. 21‐5‐2014. Ref Type: Online Source;2008.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3